Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Oruka Therapeutics, Inc. (ORKA) had Weighted-Average Shares Outstanding (Basic) of 44.07M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-30.28M |
|
-- |
|
-- |
|
$34.10M |
|
$-34.10M |
|
$3.83M |
|
$-30.28M |
|
$-30.28M |
|
$-30.28M |
|
$-30.28M |
|
$-30.28M |
|
$-30.28M |
|
$-34.10M |
|
$-35.12M |
|
|
Weighted-Average Shares Outstanding (Basic) |
44.07M |
44.07M |
|
$-0.55 |
|
$-0.55 |
|
| Balance Sheet Financials | |
$355.16M |
|
$0.25M |
|
$154.09M |
|
$509.25M |
|
$20.97M |
|
-- |
|
$1.49M |
|
$22.46M |
|
$483.86M |
|
$486.79M |
|
$486.79M |
|
48.38M |
|
| Cash Flow Statement Financials | |
$-65.62M |
|
$-74.72M |
|
$170.02M |
|
$61.58M |
|
$91.25M |
|
$29.68M |
|
$20.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-65.76M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.26% |
|
-6.22% |
|
-5.95% |
|
-6.22% |
|
$10.06 |
|
$-1.49 |
|
$-1.49 |
|